GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Pretax Margin %

Microba Life Sciences (ASX:MAP) Pretax Margin % : -351.70% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Microba Life Sciences's Pre-Tax Income for the six months ended in Dec. 2023 was A$-11.51 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2023 was A$3.27 Mil. Therefore, Microba Life Sciences's pretax margin for the quarter that ended in Dec. 2023 was -351.70%.

The historical rank and industry rank for Microba Life Sciences's Pretax Margin % or its related term are showing as below:

ASX:MAP' s Pretax Margin % Range Over the Past 10 Years
Min: -282.88   Med: -239.14   Max: -233.86
Current: -282.88


ASX:MAP's Pretax Margin % is ranked worse than
83.49% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.805 vs ASX:MAP: -282.88

Microba Life Sciences Pretax Margin % Historical Data

The historical data trend for Microba Life Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Pretax Margin % Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Pretax Margin %
-244.42 -233.86

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % - - -264.02 -213.98 -351.70

Competitive Comparison of Microba Life Sciences's Pretax Margin %

For the Diagnostics & Research subindustry, Microba Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microba Life Sciences's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Pretax Margin % falls into.



Microba Life Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Microba Life Sciences's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-12.675/5.42
=-233.86 %

Microba Life Sciences's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-11.511/3.273
=-351.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microba Life Sciences  (ASX:MAP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Microba Life Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines